Led by University of Cincinnati and Cincinnati Children’s researchers, new trial results published in The Lancet Psychiatry found the drug metformin can help manage weight gain in youth taking ...
Cobenfy, the first new schizophrenia drug in 50 years, offers early insights that could pave the way for more personalized ...
The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for ...
The Dutchman had been charged with allegations of drug trafficking, assault causing bodily harm, destruction of property and ...
News-Medical.Net on MSN
Researchers identify patient response patterns to novel schizophrenia medication
Each year, about 100,000 Americans experience psychosis, a serious condition that disrupts thoughts and perceptions so ...
A new study examining real-world hospital data reveals early indicators of who is most likely to benefit from Cobenfy, the ...
Medpage Today on MSN
ADHD Drug Recall; Postpartum Psychosis; Antibiotic for Schizophrenia Risk?
Sun Pharmaceutical issued a voluntary recall of lisdexamfetamine dimesylate capsules, used for attention ...
The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, ...
Caplyta, the crown jewel of Johnson & Johnson's $14.6 billion buyout of Intra-Cellular Therapies, won the FDA’s blessing to ...
BD2 is a $100+ million initiative dedicated to funding and advancing research to improve the lives of people living with bipolar disorder. "This is a very ambitious project," said principal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback